We found that MITF transcript levels did not correlate with CD200, a proxy of ERK activation, which agrees with the conclusions of others that if ERK activation caused by, for example, BRAF mutation, regulates MITF expression in melanoma then it is only weakly so at the level of transcription. The gene discussed is BRAF; the disease is melanoma.